 whether it's the national cancer guidelines or in their own internal guidelines. So now all of a sudden we have a drug that's FDA approved that we know has made magnificent changes in the overall survival of patients, but we can't prescribe it because it hasn't been updated in the insurance company's guidelines yet. And that is when we get even more frustrated. And then again, we have to advocate for our patients.